Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report

By sjmartinez • June 4, 2024

Lam K, Gates GA, Bach DQ, Cheng K. Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report. Case Rep Dermatol. 2024 May 28;16(1):133-139. doi: 10.1159/000539058. PMID: 38831934; PMCID: PMC11147515.

Tags: binimetinib, BRAF inhibitor, BRAF V600E, Case report, Cetuximab, Dermatology, EGFR inhibitor, Encorafenib, Eruptive melanocytic nevi, MEK inhibitor, Publications

Related Posts

Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients

Korouri E, Jeong C, Peterson H, Valenzuela F, Romiti R, Didaskalu JA, Egeberg A, Oon HH, Maul LV, Kingston P, Lee K, Huang MY, Yee[...]

Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair

Ramadoss S, Qin J, Tao B, Thomas NE, Cao E, Wu R, Sandoval DR, Piermatteo A, Grunddal KV, Ma F, Li S, Sun B, Zhou[...]

A humanized monoclonal antibody targeting an ectonucleotidase rescues cardiac metabolism and heart function after myocardial infarction

Li S, Tao B, Wan J, Montecino-Rodriguez E, Wang P, Ma F, Sun B, Gu Y, Ramadoss S, Su L, Sun Q, Hoeve JT, Stiles[...]